Cancer

More U.S. prostate cancer patients choosing active surveillance

A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

On hand for a recent celebration of the new research fund were Debra Friedman, MD, MS, left, and Brianna Smith, MD, MS, (holding the plaque) and, from right, Larisa and Phillip Featherstone with their daughters Lily, Sophie and Sophia, and Carol and Ron Johnston.

Family’s gift will support pediatric cancer research

Lily Hensiek’s family has made a new $1 million commitment to endow the Lily’s Garden Discovery Researcher Fund in the Division of Pediatric Hematology and Oncology in the Department of Pediatrics at Vanderbilt University Medical Center.

New treatment helps mitigate hair loss for chemotherapy patients

Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.

Sandler named co-chair of ACR’s Lung Cancer Screening Steering Committee

Vanderbilt’s Kim Sandler, MD, has been named co-chair of the Lung Cancer Screening Steering Committee for the American College of Radiology.

Improving lung nodule diagnosis

Adding blood and imaging biomarkers to a clinical prediction model could improve diagnostic accuracy for the 1.6 million lung nodules detected each year, many through expanded lung cancer screening programs.

Research by Mingjian Shi, PhD, left, Jonathan Mosley, MD, PhD, Kerry Schaffer, MD, MSCI, and colleagues found that polygenic risk score does not improve prediction of aggressive prostate cancer.

Study evaluates polygenic risk score for prostate cancer risk prediction

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

1 6 7 8 9 10 65